The mcdonald criteria, used for diagnosing multiple sclerosis, have been revised. The updated criteria may allow for earlier treatment for patients and incorporate biomarkers to improve diagnosis. The revisions, referred to as the 2024 mcdonald criteria, have been reported on by various medical and health outlets.